Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Morphosys AG (OTC Pink - Current Information:MPSYY)

36.67
Delayed Data
As of Aug 27
 0.00 / 0.00%
Today’s Change
30.51
Today|||52-Week Range
53.89
-20.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.9B

Company Description

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec. The Partnered Discovery segment involves technologies for the generation of human antibody therapeutics, which are exploited through partnerships with pharmaceutical and biotechnology companies. The Proprietary Development segment includes activities relating to proprietary therapeutic antibody development. The AbD Serotec segment leverages the company's core technological capabilities in the design and manufacture of antibodies for research and diagnostic purposes. The company was founded by Andreas Plückthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Contact Information

MorphoSys AG
Lena-Christ-Strasse 48
Planegg Bayern (bavaria) 82152
P:(498) 989-9270
Investor Relations:
498989927122

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Simon E. MoroneyChief Executive Officer
Jens HolsteinChief Financial Officer
Marlies SprollChief Scientific Officer
Silvia DermietzelSenior Vice President & Head-Human Resources
Claudia Gutjahr-LöserVice President, Head-Corporate Communications & IR